AI assistant
Natera, Inc. — Director's Dealing 2018
Oct 17, 2018
30253_dirs_2018-10-17_6fb97807-5cc2-49c6-94d5-a239a76e0402.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2018-10-15
Reporting Person: Sheena Jonathan (Director, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-15 | Common Stock | M | 25491 | $1.141 | Acquired | 372583 | Direct |
| 2018-10-15 | Common Stock | M | 8233 | $2.6569 | Acquired | 380816 | Direct |
| 2018-10-15 | Common Stock | S | 33724 | $20.2666 | Disposed | 347092 | Direct |
| 2018-10-15 | Common Stock | S | 50672 | $20.2882 | Disposed | 296420 | Direct |
| 2018-10-16 | Common Stock | M | 16276 | $1.141 | Acquired | 312696 | Direct |
| 2018-10-16 | Common Stock | S | 7100 | $20.6233 | Disposed | 305596 | Direct |
| 2018-10-16 | Common Stock | S | 9176 | $21.2194 | Disposed | 296420 | Direct |
| 2018-10-16 | Common Stocj | S | 11791 | $20.5347 | Disposed | 284629 | Direct |
| 2018-10-16 | Common Stock | S | 54204 | $21.2015 | Disposed | 230425 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-10-15 | Stock Option (right to buy) | $1.141 | M | 25491 | Disposed | 2022-09-19 | Common Stock (25491) | Direct |
| 2018-10-15 | Stock Option (right to buy) | $2.6569 | M | 8233 | Disposed | 2024-02-25 | Common Stock (8233) | Direct |
| 2018-10-16 | Stock Option (right to buy) | $1.141 | M | 16276 | Disposed | 2022-09-19 | Common Stock (16276) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018.
F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.92 to $20.64 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The option shares vest fully and became exercisable on July 8, 2015.
F5: The option shares vest fully and became exercisable on February 25, 2014.
F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.07 to $21.06 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.07 to $21.36 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.41 per share, inclusive. The holder undertakesto provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10: The Form 4 filed on November 25, 2016 ("Prior Filing") reflects an exercise of a stock option for 25,895 shares. The Prior Filing inadvertently included the exercise of 2,413 shares from a separate option granted to the Reporting Person on the same date understating the total amount beneficially owned following the reported transaction by 2,413 shares. The aggregate number of shares exercised on November 22, 2016 is correct as shown in Column 5. Prior to the transactions reported on this Form 4 the Reporting Person had a total of 41,767 shares remaining to exercise under the stock option.